Pathology Industry in North America: Market Research Reports, Statistics and Analysis

You might be interested in: cancer, diabete, cardiovascular disease, more »

» Download Public Reports

27 reports
Company Report: Pathology in Australia and North America for Year 2012

Company Report: Pathology in Australia and North America for Year 2012

  • Company report
  • May 2012
  • 3 pages

... To the company S future. If the marketing of bioniche S bladder cancer drug (urocidin ) Is successful, then the shares at current prices are substantially undervalued. For more on bioniche, see e ...

Oncogenex Pharmaceuticals Inc. - Investment Analysis, December 20 ...

December 2012

Company Report: Pathology In Australia And North America For Year ...

May 2012

Company Report: Pathology In North America For Year 2012

November 2012

Pathology Market In North America And Europe

August 2010

Pathology Business In South America And North America

June 2010

Global Infectious Disease Market Overview

October 2010

Infectious Disease Business In North America And Europe

November 2010

Pharmaceutical Industry In North America

September 2012

Prostate Cancer Business (prostate Cancer, Colorectal Cancer, Col ...

June 2012

» Purchase Premium Reports (From $ 250 - $ 250)

About 100 reports
Dana-Farber Cancer Institute - Medical Equipment - Deals and Alliances Profile

Dana-Farber Cancer Institute - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2013
  • by Global Data

Summary Dana-Farber Cancer Institute, Inc. (Dana-Farber) is a cancer research center. The company offers treatment for different types of cancers. It conducts community-based programs related to cance ...


» Read our Company Profiles

3 Companies

Eli Lilly and Co.

United States

AstraZeneca PLC

United Kingdom

Pfizer Inc.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.